We are live on
!
Find out more
WANY
Wealthspire Advisors (New York) Portfolio holdings
AUM
$12.7B
1-Year Est. Return
17.31%
This Fund
S&P 500
This Quarter
Est. Return
+16.65%
1 Year Est. Return
+17.31%
3 Year Est. Return
+47.87%
5 Year Est. Return
+46.91%
10 Year Est. Return
–
AUM
$1.44B
AUM Growth
-$950M
(-40%)
Cap. Flow
-$1.25B
Cap. Flow
% of AUM
-87.17%
Top 10 Holdings %
Top 10 Hldgs %
62.03%
Holding
577
New
19
Increased
26
Reduced
230
Closed
296
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$4.97M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$3.38M |
| 3 |
Royalty Pharma
RPRX
|
+$2.6M |
| 4 |
Invesco Taxable Municipal Bond ETF
BAB
|
+$2.4M |
| 5 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$1.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$125M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$101M |
| 3 |
Accenture
ACN
|
+$82.5M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$77.6M |
| 5 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$51.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.88% |
| 2 | Financials | 3.35% |
| 3 | Healthcare | 2.45% |
| 4 | Communication Services | 1.71% |
| 5 | Consumer Discretionary | 1.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Exelon
EXC
$47B
| $218K | 0.02% |
8,408
-14,011
| -62% | -$372K |
|
252
Simon Property Group
SPG
$72.3B
| $218K | 0.02% |
+3,183
| New | +$200K |
|
253
AstraZeneca
AZN
$250B
| $217K | 0.02% |
2,052
-7,813
| -79% | -$807K |
|
254
Genuine Parts
GPC
$18.7B
| $209K | 0.01% |
2,406
-3,881
| -62% | -$306K |
|
255
Invesco Dorsey Wright Momentum ETF
PDP
$1.5B
| $209K | 0.01% |
+3,106
| New | +$194K |
|
|
PBCT
256
DELISTED
People's United Financial Inc
PBCT
| $209K | 0.01% |
18,067
-1,991
| -10% | -$23.2K |
|
257
Kinder Morgan
KMI
$68.7B
| $207K | 0.01% |
13,659
-33,800
| -71% | -$514K |
|
258
Valero Energy
VLO
$85.9B
| $207K | 0.01% |
3,524
-4,484
| -56% | -$268K |
|
259
DuPont de Nemours
DD
$19.2B
| $205K | 0.01% |
3,078
-2,978
| -49% | -$174K |
|
260
Xcel Energy
XEL
$48.8B
| $204K | 0.01% |
3,266
-2,335
| -42% | -$147K |
|
|
EVM
261
DELISTED
Eaton Vance California Municipal Bond Fund
EVM
| $203K | 0.01% |
18,245
-2,030
| -10% | -$21.9K |
|
262
Allstate
ALL
$67.5B
| $202K | 0.01% |
2,087
-3,300
| -61% | -$324K |
|
263
Global Payments
GPN
$22.8B
| $201K | 0.01% |
1,186
-3,709
| -76% | -$617K |
|
|
SCHW
264
Charles Schwab
SCHW
$187B
| $200K | 0.01% |
5,929
-8,330
| -58% | -$298K |
|
265
Ford
F
$55.7B
| $173K | 0.01% |
28,415
-17,607
| -38% | -$97.5K |
|
266
Devon Energy
DVN
$47.3B
| $145K | 0.01% |
12,810
+446
| +4% | +$5.09K |
|
|
MRO
267
DELISTED
Marathon Oil Corporation
MRO
| $136K | 0.01% |
22,286
+5,614
| +34% | +$31K |
|
268
Regions Financial
RF
$26.8B
| $134K | 0.01% |
12,042
-9,228
| -43% | -$98.2K |
|
269
ICICI Bank
IBN
$108B
| $119K | 0.01% |
12,809
-38,473
| -75% | -$342K |
|
|
MNK
270
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $107K | 0.01% |
40,000
+14,668
| +58% | +$44K |
|
|
VLRS
271
Controladora Vuela Compania de Aviacion
VLRS
$939M
| $105K | 0.01% |
+19,825
| New | +$93.6K |
|
|
JPS
272
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
| $95K | 0.01% |
11,235
| – | – |
|
|
273
Royalty Pharma
RPRX
$25.3B
| $85K | 0.01% |
+52,560
| New | +$2.6M |
|
|
GARS
274
DELISTED
Garrison Capital Inc.
GARS
| $56K | ﹤0.01% |
+16,500
| New | +$40.5K |
|
275
Banco Santander
SAN
$210B
| $48K | ﹤0.01% |
+20,574
| New | +$45K |
|
Similar funds
ACA
ZIG
IMPI
AIM
ECM
TRSOTSOK
GC
Wealthspire Advisors (New York)'s Q2 2020 Portfolio in Review
As of Q2 2020, Wealthspire Advisors (New York) held 577 positions worth $1.44B, down 40% from $2.39B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Wealthspire Advisors (New York) withdrew a net $1.25B in Q2 2020, closing 296 positions and reducing 230 holdings. Its most notable exit was Schwab US Large- Cap ETF, an estimated $38.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Wealthspire Advisors (New York) opened a new position in Royalty Pharma worth $85K.
- Wealthspire Advisors (New York)'s largest Q2 2020 buy was Royalty Pharma: 52,560 shares worth $85K.
- Wealthspire Advisors (New York) added most to CME Group in Q2 2020, an estimated $4.97M increase.
- Wealthspire Advisors (New York)'s biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $125M.
- Wealthspire Advisors (New York) fully exited Schwab US Large- Cap ETF in Q2 2020, selling an estimated $38.9M.
- Wealthspire Advisors (New York)'s ten largest holdings make up 62% of its $1.44B portfolio in Q2 2020.
- Wealthspire Advisors (New York) opened 19 new positions and closed 296 in Q2 2020.
- Wealthspire Advisors (New York)'s portfolio value fell 40% quarter-over-quarter to $1.44B.
Based on Wealthspire Advisors (New York)'s 13F filing for Q2 2020, filed 14 Aug 2020.